A study for a 64 year old woman who takes Xalatan, Clindamycin Hydrochloride - from FDA reports


Summary

6 females aged 64 (±5) who take the same drugs are studied. This is a personalized study for a 64 year old female patient who has Glaucoma, Skin Infection. The study is created by eHealthMe based on reports from FDA.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>


On Dec, 27, 2017

6 females aged 64 (±5) who take Xalatan, Clindamycin Hydrochloride are studied.


Number of reports submitted per year:

Xalatan, Clindamycin Hydrochloride for a 64-year old woman.

Information of the patient in this study:

  • Age: 64
  • Gender: female
  • Conditions: Glaucoma, Skin Infection
  • Drugs taken:
    • Xalatan (latanoprost)
    • Clindamycin Hydrochloride (clindamycin hydrochloride)

eHealthMe real world results:

Comparison with this patient's adverse outcomes:

  • Blurred Vision: 0 (0% of females aged 64 (±5) who take the drugs)

As an adverse outcome could be a symptom of a condition, additional studies are listed to help identify the cause: for example, regardless of which drug is taken, how many female HBP patients aged 50 (±5) have nausea

As an adverse outcome could be a side effect of a drug, additional studies are listed to help identify the cause: for example, how many female Aspirin users aged 50 (±5) have nausea

Most common drug interactions over time

< 1 month:
  • taste - impaired
  • neck pain
  • headache
1 - 6 months:
n/a
6 - 12 months:
n/a
1 - 2 years:
n/a
2 - 5 years:
n/a
5 - 10 years:
n/a
10+ years:
n/a
not specified:
  • leukocytosis
  • bradycardia
  • blood sodium decreased
  • pulmonary oedema
  • cardiac failure congestive
  • memory loss
  • blood creatinine increased
  • heart rate irregular
  • cardiac arrest
  • agitation

Top conditions involved for these people *:

  • Primary Pulmonary Hypertension (2 people, 33.33%)
  • Psoriasis (1 person, 16.67%)
  • Migraine (1 person, 16.67%)
  • Eye Disorder (1 person, 16.67%)
  • Blast Crisis In Myelogenous Leukaemia (1 person, 16.67%)

Top co-used drugs for these people *:

  • Premarin (3 people, 50.00%)
  • Vytorin (2 people, 33.33%)
  • Revatio (2 people, 33.33%)
  • Procardia (2 people, 33.33%)
  • Letairis (2 people, 33.33%)

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Want to find out more about the FDA reports used in the study? You can request them from FDA.

You can also:

Expand the study to include reports from both FDA and eHealthMe

Expand this study to include FDA and eHealthMe reports

What are the drugs?

What are the conditions?

What are the symtoms?

  • Blurred vision has been reported by people with high blood cholesterol, gastroesophageal reflux disease, generalized anxiety disorder, attention deficit hyperactivity disorder, high blood pressure (latest reports from 655 Blurred vision patients).

Could your drugs cause:

Could your conditions cause:

Related studies:

Can you answer these questions?

More questions for: Xalatan, Clindamycin hydrochloride, Skin infection Glaucoma Blurred vision

You may be interested in these posts

More posts for: Xalatan, Clindamycin hydrochloride, Skin infection Glaucoma Blurred vision